Spain's austerity cull on hold - HTA and centralised procurement on track
This article was originally published in Clinica
Executive Summary
Two projects of significance to the medtech and pharma sectors in Spain took centre stage last week in government discussions centred around healthcare cost-cutting. The planned national health technology assessment (HTA) agency, to be modelled on the UK’s NICE, has been formally approved for passage into law; and there is progress with the planned expansion of the centralised vaccines-purchasing “platform” to include medtech and pharma – a proposed list of target products is close to being unveiled.